Submit Deal

Kazumi Kobayashi

Communications Director at TAKEDA PHARMACEUTICAL COMPANY LIMITED

Manager

Deal Bio

Total Deals8

Valued Deals8

Total Value£4,239M

Avg. Deal Size£530M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (8)

Sort

Netherlands

Biotechnology

PublicAcquisitionMajority

target

Tigenix

bidder

Takeda Pharmaceutical Company

£445m

12 dealmakers

Ukraine

Pharmaceuticals

AcquisitionMajorityPrivateCross BorderPrivate Equity

target

Takeda Pharmaceutical Company (drug Portfolio)

bidder

Acino International

£159m

24 dealmakers

Russian Federation

Pharmaceuticals

MajorityAcquisitionPrivateCross Border

target

Takeda Pharmaceutical Company (otc Portfolio)

bidder

Stada Arzneimittel

£512m

37 dealmakers

United States

Pharmaceuticals

AcquisitionPrivateMajorityCross Border

target

Pvp Biologics

bidder

Takeda Pharmaceutical Company

£255m

12 dealmakers

Japan

Health Care Services

PrivateAcquisitionMajorityPrivate EquityCross Border

target

Takeda Consumer Healthcare Company

bidder

Blackstone Group

£1,756m

38 dealmakers

Japan

Medical Equipment

MajorityPrivateCross BorderAcquisitionPrivate Equity

target

Takeda (tachosil)

bidder

Gtcr

£320m

78 dealmakers

Japan

Medical Supplies

PrivateMajorityCross BorderAcquisition

target

Takeda Pharmaceutical Company (prescription Products)

bidder

Cheplapharm Arzneimittel Gbmh

£412m

7 dealmakers

United States

Pharmaceuticals

PrivateMajorityAcquisitionCross Border

target

Maverick Therapeutics

bidder

Takeda Pharmaceutical Company

£379m

12 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy